Skip to main content
. 2015 Feb 5;24(3):256–261. doi: 10.1002/pds.3761

Table 3.

Risk of being prescribed oral corticosteroids over time among patients treated with valproic acid or phenytoin

Unadjusted hazard ratio (95% CI)* Adjusted hazard ratio (95% CI)*
Secondary outcome: prescription for oral corticosteroid
Day 0 to 30 0.26 (0.18 to 0.40) 0.32 (0.21 to 0.49)
Day 31 to 60 0.62 (0.42 to 0.92) 0.74 (0.48 to 1.12)
Day 61 to 90 0.86 (0.56 to 1.34) 1.02 (0.64 to 1.61)
Day 91 to 120 0.89 (0.56 to 1.44) 1.04 (0.64 to 1.71)
Day 121 to 150 0.70 (0.42 to 1.18) 0.81 (0.47 to 1.39)
Day 151 to 180 0.89 (0.5 to 1.57) 1.03 (0.57 to 1.85)
Day 181 to 210 1.32 (0.77 to 2.29) 1.53 (0.87 to 2.67)
Day 211 to 240 0.69 (0.35 to 1.35) 0.80 (0.40 to 1.58)
*

Reference group is individuals treated with phenytoin. Models adjusted for propensity score, age, sex, Charlson co-morbidity score, residence in long-term care facility, number of prescription drugs in previous year, xanthine use, stroke/transient ischemic attack, seizure disorder and lung malignancy.